Skip to content

Chain Drug Review

CVS beats Q2 revenue and profit forecasts

CVS beats Q2 revenue and profit forecasts

CVS Health topped Wall Street’s estimates for the top and bottom lines for the second quarter ended June 30. Revenue, driven by growth across segments, rose 10.3% to $88.9 billion, exceeding analysts’ forecast of an $86.45 billion. While adjusted earnings dipped 12.6% from the year-ago period to $2.

HDA presents DIANA Awards

HDA presents DIANA Awards

The Healthcare Distribution Alliance (HDA) honored nine pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at its 2023 Business and Leadership Conference. The DIANA is one of HDA’s highest honors.